Detail
| LncRNA Name | NORAD |
| Synonyms | NORAD, LINC00657, ASHGA5P032173 |
| Region | GRCh38_20:36045622-36050960 Sequence |
| Ensembl | ENSG00000260032 |
| RefSeq | NR_027451 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | esophageal squamous cell cancer |
| ICD-0-3 | |
| Methods | qPCR |
| Sample | esophageal squamous cell carcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | The relative expression levels of NORAD were significantly upregulated in tumor tissues (p < 0.001) compared to adjacent normal tissues. In addition, high expression of NORAD was correlated with larger tumor size (p =0.021) and T stage (p = 0.045). Kaplan-Meier analysis indicated that patients with high NORAD expression had poor overall and disease-free survival (p < 0.001). |
| Pubmed ID | 28482344 |
| Year | 2017 |
| Title | NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma |
| External Links |
| Links for NORAD | GenBank HGNC lncrnadb Noncode |
| Links for esophageal squamous cell cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.